IndiaTickerLatest filing: Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
ObservedCompany dossier
Ajanta Pharma
NSE:AJANTPHARM · ISIN INE031B01049
- Close
- ₹3,396.5 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Ajanta Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹1,146.1 Cr · PAT ₹232.9 Cr.
Exchange XBRLLatest ownership: promoter group 63.48% and public 36.52% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
BSE · shareholding
Observed
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · exchange filing
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Ajanta Pharma Limited
NSE · conference call
Observed
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹1,146.1 Cr
- Profit after tax
- ₹232.9 Cr
- EPS
- ₹18.60
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 63.48%
- Public
- 36.52%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL